QA: Alimera Sciences INC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001267602_2020_Alimera_Sciences_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}
info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest'}

Graph

Absolute values for 0001267602, Alimera Sciences INC

  xvar xval
0 AssetsCurrent 32,745,000
1 IntangibleAssetsNetIncludingGoodwill 14,783,000
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 2,781,000
4 LiabilitiesCurrent 12,048,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 13,826,477
9 ResearchAndDevelopmentExpense 10,961,136
10 remainder_Expenses 39,523,076
11 remainder_Revenues 70,134,958
12 remainder_NetIncome -530,382
13 remainder_ComprehensiveNetIncome -112,022
  yvar yval
0 Assets 50,309,000
1 Liabilities 12,048,000
2 Expenses 64,310,689
3 Revenues 70,134,958
4 StockholdersEquity 38,261,000
5 NetIncome 5,293,887
6 ComprehensiveNetIncome 5,237,876
7 BaseVar 98,722,526
8 EconomicCapitalRatiobeforeLimitedLiability 2.84
9 EconomicCapitalRatio 3.58

Edgar->Model Mapping

Feature Distribution

Change over Time